Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
08/16/1989 | EP0327877A2 Peptide-renininhibitors |
08/16/1989 | EP0327808A1 Substituted 3-aminosydnonimines, process for their preparation and their use |
08/16/1989 | EP0327800A2 6-Phenyldihydro-3(2H)-pyridazinones, process for their preparation and medicines containing these compounds |
08/16/1989 | EP0327766A2 Redox systems for brain-targeted drug delivery |
08/16/1989 | EP0327765A1 Dietary supplement and method for the treatment of menopause and manifestations of aging |
08/16/1989 | EP0327709A2 Novel platinum complex, antineoplastic agent containing the same, intermediate therefor, preparation method and use |
08/16/1989 | EP0327590A1 7-deazaguanines as immunomodulators |
08/16/1989 | CN1034731A 11-arylsteroid compounds |
08/16/1989 | CN1034727A Crystals of cephem hydrochloride |
08/16/1989 | CN1034726A Stabilizing agent and injectable composition containing same |
08/16/1989 | CN1034725A Pharmaceutical compounds |
08/16/1989 | CN1034724A Water soluble camptothecin analogs |
08/16/1989 | CN1034723A New 6-substituted mitomycin analogs |
08/16/1989 | CN1034722A Triazolo (4.3-a)(1,4) benzodiazepine and thiopheno (3,2-f) (1,2,4) triazolo (4,3-a) (1,4) diazepine |
08/16/1989 | CN1034721A Sulfhydryl containing tricyclic lactams and their pharmacological methods of use |
08/16/1989 | CN1034720A Use of dihydropyridine-3,5-dihydroxy acid easter derivatives |
08/16/1989 | CN1034718A Novel (aryl or heteroaromatic methyl)-2,2' bi-1h-imidazoles |
08/16/1989 | CN1034716A Disubstituted pyridines and process for preparing same |
08/16/1989 | CN1034710A Compounds |
08/16/1989 | CN1034709A Process for preparing substituted styrene derivatives |
08/16/1989 | CN1034670A Process for stabilizing cephalosporins derivatives by drying them with stabiliser and stability composition containing cephalosporins derivatives |
08/15/1989 | USRE33024 Bronchodilating 8-hydroxy-5-(1R)-1-hydroxy-2-(N-((1R)-2-(p-methoxyphenyl)-1-methylethyl)-amino)ethyl) carbostyril and intermediates thereof |
08/15/1989 | US4857662 N-phenylbenzamide derivatives |
08/15/1989 | US4857660 Enzyme inhibitors, anticancer agents |
08/15/1989 | US4857647 Dopamine antagonist |
08/15/1989 | US4857643 Antitussive and mucus regulating 2-substituted thiazolidines |
08/15/1989 | US4857641 C.12 modified erythromycin A derivatives |
08/15/1989 | US4857558 Antiinflammatory agents and-or antiallergens |
08/15/1989 | US4857555 Administering glutamine |
08/15/1989 | US4857554 Ointment containing ursolic acid and oleanolic acid in vaseline/lanolin carrier |
08/15/1989 | US4857553 Method of treating nausea and vomiting with certain substituted-phenylalkylamino (and aminoacid) derivatives and other serotonin depleting agents |
08/15/1989 | US4857552 Degradable esmolol hydrochloride for cardiovascular disorders; short action, shelf life |
08/15/1989 | US4857548 Method of preventing or reducing platelet loss during extracorporeal circulation using a thromboxane A2 receptor antagonist |
08/15/1989 | US4857547 Novel HMG-CoA reductase inhibitors |
08/15/1989 | US4857546 Anticholesterol, antilipemic agents |
08/15/1989 | US4857544 Parasiticides |
08/15/1989 | US4857543 Treatment of gastrointestinal disorders |
08/15/1989 | US4857539 Heterocyclic substituted-phenoxyalkylisoxazoles as antiviral useful agents |
08/15/1989 | US4857536 Antihistaminic benzimidazole derivatives |
08/15/1989 | US4857534 Method of maintaining ruminants on high energy low fiber diet |
08/15/1989 | US4857533 Method of treatment for autoimmune diseases |
08/15/1989 | US4857530 Substituted quinazolinones as anticancer agents |
08/15/1989 | US4857529 Interferon inducing, anti-vaccinia, and/or anti-influenza compositions |
08/15/1989 | US4857528 Substituted pyrrolidinones, pharmaceutical compositions and use |
08/15/1989 | US4857525 Quaternary ammonium retinoates, their use in cosmetics and in dermopharmacy |
08/15/1989 | US4857523 Rapid method for attenuating the alcohol dependency syndrome |
08/15/1989 | US4857521 Trialkylsilyl pyridinium cephalosporin antibiotics |
08/15/1989 | US4857520 Fused azepinone and azocinone derivatives, processes for their preparation, agents containing them and their use, and intermediates in their preparation |
08/15/1989 | US4857519 Novel pharmaceutical compositions endowed with anti-progesteronic properties and a process for making the same |
08/15/1989 | US4857515 Certain antihypertensive 1,4-dihydro-6-methyl-5-phosphonic acid-4-aryl-3-carboxylic acid-2-cyano diesters |
08/15/1989 | US4857514 Virus inactivation |
08/15/1989 | US4857512 Immunostimulating polysaccharides, method for using such, and pharmaceutical preparations containing them |
08/15/1989 | US4857509 13β-alkylmilbemycin derivatives for controlling parasites of animals and plants |
08/15/1989 | US4857337 Enteric coated aspirin tablets |
08/15/1989 | US4857336 Oral therapeutic system having systemic action |
08/15/1989 | US4857330 Osmotic dosage form |
08/15/1989 | US4857327 Method for suppressing states of illness in the digestive system |
08/15/1989 | US4857315 Compositions containing golgi alpha-mannosidase II inhibitors |
08/15/1989 | US4857312 Dihydropyridine spray, process for its preparation and its pharmaceutical use |
08/15/1989 | US4857311 Polyanhydrides with improved hydrolytic degradation properties |
08/15/1989 | US4857310 Skin moisturizing, hair conditioner |
08/15/1989 | US4857302 Solubilized benzoyl peroxide and cosmetic solution including solubilized benzoyl peroxide |
08/15/1989 | CA1258464A1 1,3-dioxan-5-ylalkenoic acids |
08/15/1989 | CA1258463A2 1,5-benzoxathiepin derivatives, their production and use |
08/15/1989 | CA1258462A2 1,5-benzoxathiepin derivatives, their production and use |
08/15/1989 | CA1258461A1 2-azolylmethyl-3-difluorobenzyloxy-2,3- dihydrofluorobenzo¬b|thiophene antifungal compounds and method of using same |
08/15/1989 | CA1258459A1 4-substituted amino-ethylene-phenol compounds |
08/15/1989 | CA1258456A1 Aryl or hetero-aryl derivatives of 1-hydroxy-pentane or 1-hydroxy-hexane for treating inflammation and allergies |
08/15/1989 | CA1258454A1 Phenethanolamines |
08/15/1989 | CA1258453A1 Piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain |
08/15/1989 | CA1258452A1 Organic synthesis process of oligosaccharides containing galactosamine- uronic acid motives, oligosaccharides thus obtained and their biological uses |
08/15/1989 | CA1258432A1 Blood coagulant |
08/15/1989 | CA1258430A1 Cough/cold mixtures comprising non-steroidal anti- inflammatory drugs |
08/15/1989 | CA1258423A1 Antimicrobial surface degerming compositions and method of use thereof |
08/10/1989 | WO1989007103A1 Pyranobenzoxadiazole derivatives |
08/10/1989 | WO1989007099A1 2,2-disubstituted glycerol and glycerol-like compounds, compositions and methods of use |
08/10/1989 | WO1989006979A1 Paramagnetic compounds |
08/10/1989 | WO1989006977A1 Formulation and use of retinoids in treatment of cancer and other diseases |
08/10/1989 | WO1989006964A1 Ophthalmic suspensions |
08/10/1989 | WO1989006963A1 Acidic polycyclic ether antibiotic having anticoccidial and growth promotant activity |
08/10/1989 | WO1989006962A1 Silver sulfadiazine-containing agent for topical external therapy |
08/10/1989 | WO1989006961A1 Antianxiety drug |
08/10/1989 | WO1989006960A2 Use of anisodamine to prevent and treat eye disease |
08/10/1989 | WO1989006959A1 Pharmaceutical composition having improved releasability |
08/10/1989 | WO1989006958A1 Topical l-carnitine composition |
08/10/1989 | DE3802895A1 Combination product for the treatment of disorders and injuries of nerve cells and nerve fibres |
08/09/1989 | EP0327523A1 Novel fatty acid analog enzyme substrates |
08/09/1989 | EP0327500A2 5-Substituted 1H-pyrazolo[3,4-b]pyridine derivatives, their preparation and pharmaceutical compositions containing them |
08/09/1989 | EP0327455A1 Alkyl or benzyl ethers of phenol, processes for their preparation and their therapeutical use |
08/09/1989 | EP0327426A1 Indolo[3,2,1-de][1,4]-oxazino[2,3,4-ij][1,5]naphthyridine derivatives, process for their preparation and intermediates, their use as medicaments and compositions containing them |
08/09/1989 | EP0327365A2 Improvements in or relating to modified haptens useful as imaging and therapeutic agents |
08/09/1989 | EP0327364A1 Crystalline beta-lactam solvate |
08/09/1989 | EP0327358A2 Ceftazidime dihydrochloride formic acid solvates |
08/09/1989 | EP0327335A1 Arylamido(and arylthioamido)-azabicycloalkanes for enhancing memory or correcting memory deficiency |
08/09/1989 | EP0327327A2 Medicated cleansing pads |
08/09/1989 | EP0327326A1 Medicated cleansing pads |
08/09/1989 | EP0327307A2 Tricyclic ketone derivatives having a 5-HT3 antagonist activity |
08/09/1989 | EP0327306A2 Leukotriene B4 antagonists |
08/09/1989 | EP0327295A2 Tetracycline dosage form |
08/09/1989 | EP0327284A2 Triazolo(1,5-c)pyrimido(1,4) azines as bronchodilators |